JAK2 and rheumatoid arthritis: We aim to investigate the potential of DMWE as a novel therapeutic agent for RA by examining its ability to modulate inflammatory Janus Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription (STAT) pathways and regulate the expression of enzymes such as MMPs.